1. A MULTICENTER PILOT STUDY USING INDUCTION CHEMO-IMMUNOTHERAPY FOLLOWED BY CONSOLIDATION WITH REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANT IN ADVANCED STAGE MATURE NON-APLASTIC T/NK-CELL LYMPHOMA/ LEUKEMIA IN CHILDREN, ADOLESCENT, AND YOUNG ADULTS (CAYA). (October 2022) Authors: Xavier, A.; Harrison, L.; Miles, R.; Voss, S.; Lim, M.; Cairo, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A NOVEL CYTOKINE-ANTIBODY FUSION PROTEIN, N-820, TO ENHANCE THE FUNCTIONS OF EX-VIVO EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA. (October 2022) Authors: Chu, Y.; Nayyar, G.; Su, N.; Rosenblum, J.; Soon-Shiong, P.; Lee, J.; Safrit, J.; Barth, M.; Lee, D.; Cairo, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB FOLLOWING MYELOABLATIVE TOTAL BODY IRRADIATION (TBI)-BASED CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATON IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HIGH-RISK T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC FACILITATED STUDY. (October 2022) Authors: Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; Rosenblum, J.; Milner, J.; Pehlivan, K.; Levendoglu-Tugal, O.; Fabricatore, S.; Wolownik, K.; Ayello, J.; Rigot, O.; Klejmont, L.; Campbell, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy. (1st June 2018) Authors: Rupérez, C.; Lerin, C.; Ferrer-Curriu, G.; Cairo, M.; Mas-Stachurska, A.; Sitges, M.; Villarroya, J.; Giralt, M.; Villarroya, F.; Planavila, A. Journal: International journal of cardiology Issue: Volume 260(2018) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IBRUTINIB + CHEMOIMMUNOTHERAPY (CIT) FOR RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) IN CHILDREN (SPARKLE TRIAL): INITIAL SAFETY, PK, AND EFFICACY. (12th June 2019) Authors: Burke, A.; Beishuizen, A.; Bhojwani, D.; Burkhardt, B.; Minard‐Colin, V.; Norris, R.; Kabickova, E.; Pinarli, F.; Tacyildiz, N.; de Jong, J.; Liu, G.; Howes, A.; Nottage, K.; Salman, M.; Woot de Trixhe, X.; Cairo, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MULTICENTER PILOT TRIAL OF INTRATHECAL LIPOSOMAL CYTARABINE IN CAYA WITH MATURE DE-NOVO B-NHL. (October 2022) Authors: Goldman, S.; Barth, M.; Shiramizu, B.; Shi, Q.; Hochberg, J.; Klejmont, L.; Harrison, L.; Basso, J.; Chu, Y.; Islam, H.; Gerard, P.; Agsalda-Garcia, M.; Shieh, T.; Oesterheld, J.; Heym, K.; Kirov, I.; Drachtman, R.; Harker-Murray, P.; Perkins, S.; Miles, R. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OBINUTUZUMAB (GA101) VS. RITUXIMAB SIGNIFICANTLY ENHANCES CELL DEATH, ANTIBODY-DEPENDENT CYTOTOXICITY AND IMPROVES OVERALL SURVIVAL AGAINST CD20+ PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBL) IN A XENOGRAFT NOD-SCID IL2RGNULL (NSG) MOUSE MODEL: A POTENTIAL TARGETED AGENT IN THE TREATMENT OF PMBL. (October 2022) Authors: Chu, Y.; Awasthi, A.; Lee, S.; Edani, D.; Yin, C.; Hochberg, J.; Shah, T.; Chung, T.; Ayello, J.; van de Ven, C.; Klein, C.; Lee, D.; Cairo, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OPTIMIZING CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED NK CELL-MEDIATED CYTOTOXICITY COMBINED WITH ANTI-CD 20 OR ANTI-CD79 THERAPEUTIC ANTIBODIES AND NKTR-255 IN BURKITT LYMPHOMA (BL). (October 2022) Authors: Chu, Y.; Tian, M.; Marcondes, M.; Overwijk, W.; Lee, D.; Klein, C.; Cairo, M. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PP.05.27: ARTERIAL STRUCTURAL AND FUNCTIONAL EFFECTS OF INCRETIN THERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS. (June 2015) Authors: Maloberti, A.; Cimino, E.; Casati, M.; Villa, P.; Cairo, M.; Macchiarulo, M.; Frara, S.; Spreafico, E.; Gamba, P.; Pincelli, A.I.; Bombelli, M.; Grassi, G. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PP.21.31: COMPARISON OF THE EFFECTS OF TWO DIFFERENT ANTIHYPERTENSIVE DRUG COMBINATIONS ON ARTERIAL DISTENSIBILITY AND PULSE WAVE VELOCITY IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION. (June 2015) Authors: Cairo, M.; Van Bortel, L.M.; Seravalle, G.; Maloberti, A.; Makel, W.; Fici, F.; Mancia, G.; Grassi, G. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗